AstraZeneca chief executive Pascal Soriot has thanked the Government ‘for their efforts to improve access for patients’
Notifications can be managed in browser preferences.
Swipe for next article
AstraZeneca chief executive Pascal Soriot has thanked the Government ‘for their efforts to improve access for patients’
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
AstraZeneca makes surprise U-turn with £300m pharma investment in UK
AstraZeneca revives Cambridge investment after UK agrees to pay more for drugs
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
AstraZeneca stock falls after FDA panel votes against new cancer drug
Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer
Drug companies increasingly frustrated with the Government over surging NHS clawbacks
Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.
Drug company chairman calls for change to ‘appalling’ rules on NHS drug prices
Resumption of £300mn in UK projects is a result of trade deal with US that aims to increase medicines spending
Pascal Soriot declares his ‘love’ for US amid fears his pharma giant could quit the FTSE
